Hofseth Biocare ASA

Hofseth BioCare's ProGo® Bioactive Peptides Show Multi-Target Effects on Healthy Ageing in Peer-Reviewed Clinical Study

- A new peer-reviewed clinical study published in Biomedicines demonstrates that ProGo® Bioactive Peptides can simultaneously influence multiple biological drivers of healthy ageing, including iron metabolism, inflammation, glucose control, and body composition. - The study found that a single daily supplement of ProGo® produced effects not observed with a protein-matched comparator, suggesting unique bioactive properties beyond standard protein supplementation. - Hofseth BioCare ASA has released a companion white paper summarizing the clinical findings, while ProGo® was recently named winner in the Healthy Aging category at the 2025 NutraIngredients-USA Awards.